1. Home
  2. DH vs AURA Comparison

DH vs AURA Comparison

Compare DH & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DH
  • AURA
  • Stock Information
  • Founded
  • DH 2011
  • AURA 2007
  • Country
  • DH United States
  • AURA United States
  • Employees
  • DH N/A
  • AURA N/A
  • Industry
  • DH Computer Software: Prepackaged Software
  • AURA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DH Technology
  • AURA Health Care
  • Exchange
  • DH Nasdaq
  • AURA Nasdaq
  • Market Cap
  • DH 429.4M
  • AURA 396.8M
  • IPO Year
  • DH 2021
  • AURA 2021
  • Fundamental
  • Price
  • DH $3.86
  • AURA $6.80
  • Analyst Decision
  • DH Buy
  • AURA Strong Buy
  • Analyst Count
  • DH 7
  • AURA 6
  • Target Price
  • DH $4.90
  • AURA $22.33
  • AVG Volume (30 Days)
  • DH 416.1K
  • AURA 160.7K
  • Earning Date
  • DH 08-07-2025
  • AURA 08-15-2025
  • Dividend Yield
  • DH N/A
  • AURA N/A
  • EPS Growth
  • DH N/A
  • AURA N/A
  • EPS
  • DH N/A
  • AURA N/A
  • Revenue
  • DH $244,926,000.00
  • AURA N/A
  • Revenue This Year
  • DH N/A
  • AURA N/A
  • Revenue Next Year
  • DH $1.69
  • AURA N/A
  • P/E Ratio
  • DH N/A
  • AURA N/A
  • Revenue Growth
  • DH N/A
  • AURA N/A
  • 52 Week Low
  • DH $2.15
  • AURA $4.35
  • 52 Week High
  • DH $5.68
  • AURA $12.38
  • Technical
  • Relative Strength Index (RSI)
  • DH 47.09
  • AURA 52.26
  • Support Level
  • DH $3.98
  • AURA $6.30
  • Resistance Level
  • DH $4.09
  • AURA $6.89
  • Average True Range (ATR)
  • DH 0.23
  • AURA 0.42
  • MACD
  • DH -0.03
  • AURA -0.04
  • Stochastic Oscillator
  • DH 14.28
  • AURA 42.37

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: